Assessment of bone marrow plasma cell infiltrates in multiple myeloma: the added value of CD138 immunohistochemistry

This publication has 39 references indexed in Scilit:

• CD138 (Syndecan-1), a Plasma Cell Marker Immunohistochemical Profile in Hematopoietic and Nonhematopoietic Neoplasms
  American Journal of Clinical Pathology, 2004
• Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation
  Blood, 2002
• Syndecan-1 (CD138) Immunoreactivity in Bone Marrow Biopsies of Multiple Myeloma: Shed Syndecan-1 Accumulates in Fibrotic Regions
  Laboratory Investigation, 2001
• Usefulness and Reproducibility of Cytomorphologic Evaluations to Differentiate Myeloma From Monoclonal Gammopathies of Unknown Significance
  American Journal of Clinical Pathology, 2001
• DNA Cell Content Studies in Multiple Myeloma
  Leukemia & Lymphoma, 1996
• Prognostic relevance of a histologic classification system applied in bone marrow biopsies from patients with multiple myeloma: A histopathological evaluation of biopsies from 153 untreated patients*
  European Journal of Haematology, 1995
• VS38: a new monoclonal antibody for detecting plasma cell differentiation in routine sections.
  Journal of Clinical Pathology, 1994
• Comparison of plasma cell infiltration in bone marrow biopsies and aspirates in patients with multiple myeloma
  British Journal of Haematology, 1992
• Histology and immunohistology of bone marrow biopsy in multiple myeloma
  European Journal of Haematology, 1989
• Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging
  British Journal of Haematology, 1982